Literature DB >> 8640598

Left ventricular hypertrophy regression as a process with variable biological implications.

F Simko1.   

Abstract

OBJECTIVE: To determine whether myocardial hypertrophy regression, similarly to hypertrophy itself, is a process of variable nature with different biological implications. DATA SOURCES: Current Contents and MEDLINE searches under myocardial hypertrophy and regression of hypertrophy-related headings were conducted. DATA EXTRACTION: The search covered the period from 1969 to 1994, and 89 articles dealing with both human and animal studies were used. DATA SYNTHESIS: The positive adaptive effect of left ventricular myocardial hypertrophy may be counterbalanced by increased incidence of heart failure, myocardial infarction or sudden death. The risk of undesirable cardiovascular events varies according to the character of hypertrophic growth. Reduction of cardiac mass to that of a normal heart need not always mean that the ventricle is normal in all aspects. Several forms of left ventricular hypertrophy regression may be distinguished. The hypertrophy regression of the athletic heart is of a physiological nature. The spontaneous regression of left ventricular hypertrophy as seen in the rabbit model of aortic insufficiency has a pathological aspect resulting in heart failure. The nature of therapeutically induced regression of hypertrophy may vary according to fibrotic tissue concentration, energetical state and the function of the regressed heart.
CONCLUSION: The biological implication of hypertrophy regression varies especially with respect to the nature of hypertrophy and the mode of achievement of hypertrophied mass reversal. Only long term prospective studies can clarify the question as to which types of hypertrophy regression result in decreased cardiovascular risk.

Entities:  

Mesh:

Year:  1996        PMID: 8640598

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  4 in total

1.  The effect of enalapril and verapamil on the left ventricular hypertrophy and the left ventricular cardiomyocyte numerical density in rats submitted to nitric oxide inhibition.

Authors:  L M Pereira; C A Mandarim-De-Lacerda
Journal:  Int J Exp Pathol       Date:  2001-04       Impact factor: 1.925

2.  Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril.

Authors:  Fedor Simko; Olga Pechanova; Kristina Repova; Silvia Aziriova; Kristina Krajcirovicova; Peter Celec; Lubomira Tothova; Stanislava Vrankova; Lucia Balazova; Stefan Zorad; Michaela Adamcova
Journal:  Int J Mol Sci       Date:  2017-07-25       Impact factor: 5.923

3.  Downregulation of β-Adrenoceptors in Isoproterenol-Induced Cardiac Remodeling through HuR.

Authors:  Qian Yin; Chengzhi Yang; Jimin Wu; Haiyan Lu; Xiaohui Zheng; Youyi Zhang; Zhizhen Lv; Xiaopu Zheng; Zijian Li
Journal:  PLoS One       Date:  2016-04-01       Impact factor: 3.240

4.  Effects of a novel ACE inhibitor, 3-(3-thienyl)-l-alanyl-ornithyl-proline, on endothelial vasodilation and hepatotoxicity in l-NAME-induced hypertensive rats.

Authors:  Mahesh Kumar Seth; M Ejaz Hussain; Santosh Pasha; Mohammad Fahim
Journal:  Drug Des Devel Ther       Date:  2016-04-20       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.